Melanotan II is an unapproved synthetic peptide marketed online as an injectable that darkens skin. Here is the plain truth: it has no FDA-approved product, no lawful compounding pathway, and no legal route to buy or be prescribed it anywhere. What people order is an unregulated substance of uncertain contents, and the medical literature ties it to serious harms including muscle breakdown, kidney injury, prolonged painful erections, and changing moles. This article explains what it is and what the evidence actually shows.
What is melanotan II, really?
It is a lab-made analog of a natural hormone that signals pigment-producing cells to make more melanin. In theory that produces a tan with less sun exposure. In practice, the product changing hands is nothing like a controlled medicine. A 2014 analysis published in a peer-reviewed journal identified and characterized melanotan II tanning products sold illegally online and found the actual peptide content and purity were inconsistent with what buyers were told they were getting.
That matters more than it sounds. When a substance is injected and its dose is unknown, every reported side effect becomes harder to predict and harder to reverse. There is no batch record, no sterility guarantee, and no pharmacist verifying the vial. The word “peptide” carries a clean, clinical ring that the actual supply chain does not earn.
Is it the same thing as afamelanotide?
No, and the confusion is worth clearing up because the names look alike. Afamelanotide is a distinct, related molecule that went through clinical trials and regulatory review for erythropoietic protoporphyria, a rare inherited disorder in which sunlight causes severe pain. A 2026 study reported that afamelanotide improved quality of life and light tolerance in that population. It is delivered as a supervised implant for a narrow medical indication, not a cosmetic product for people who want a darker tan at the beach.
Melanotan II never earned that kind of evaluation. Treating one as evidence for the other is a mistake sellers are happy to encourage.
See also: The Truth About the ‘Tanning Peptide’
What does the safety literature actually document?
This is where the marketing and the case reports diverge sharply. The published harms are specific.
| Reported outcome | What the case literature describes |
|---|---|
| Systemic toxicity | A report of melanotan II injection producing systemic toxicity and rhabdomyolysis, the breakdown of muscle tissue that can threaten the kidneys. |
| Kidney injury | A case of renal infarction, loss of blood flow to part of a kidney, linked to melanotan II use. |
| Prolonged erection | Melanotan-induced priapism, a persistent painful erection that is a urologic emergency. |
| Mole changes | Eruptive new moles and darkening of pre-existing moles after a single injection. |
| Mouth lining changes | A case report of pigment changes in the oral mucosa associated with the injections. |
These are individual reports rather than incidence rates, so they cannot tell you the odds. What they do establish is that serious events happen and that they span several organ systems. The systemic toxicity and rhabdomyolysis report and the renal infarction case are not minor cosmetic complaints. The priapism report describes an outcome that sends people to emergency surgery. None of that fits the casual framing of a shortcut tan.
Why is the mole effect the one that should stop people?
Of everything on the list, the pigment changes deserve extra weight. Reports describe both new moles appearing and existing ones darkening after even a single dose. Skin cancer surveillance depends on noticing when a mole changes: new color, new size, a new spot where there wasn’t one. A drug that darkens and multiplies moles across the body does the opposite of what a dermatologist wants, muddying the exact signals used to catch melanoma early. The eruptive naevi report is short, but its implication is not small.
What about buying it anyway, quietly?
People do, which is why the honest thing is to be direct about the setup rather than pretend the demand does not exist. There is no supervised, legal channel for cosmetic melanotan II. It is not a matter of finding the right clinic or the right telehealth service. Reputable platforms in the broader wellness and prescription space, including Ro, Hims and Hers, Henry Meds, and LillyDirect, do not offer it because there is no approved product to prescribe. Informational explainers describing what people report, such as the melanotan overview published by FormBlends, can help someone understand the substance, but reading about it is not the same as it being available to buy safely, and no legitimate operation supplies it as a tanning product.
The 2014 online-product analysis is the practical counterweight to any confidence in a particular vendor. When independent researchers tested what was actually being sold, the contents did not match the claims. Trusting an anonymous seller with an injectable of unknown identity is the core problem, and it does not improve with a nicer website.
Is there a version of this that is worth it?
For cosmetic tanning, no. There is no injectable that has earned a place here. Topical sunless tanners built around DHA stain the surface layer of skin and produce color without stimulating pigment cells or entering the bloodstream, which is why they carry none of the systemic risks in the case literature. They are boring by comparison, and that is the point.
The only supervised member of this molecular family with a real evidence base is afamelanotide, and its quality-of-life data apply to a rare light-sensitivity disease, not to appearance. If a genuine pigment or light-tolerance condition is in play, that is a conversation for a specialist, not an online vial.
Key takeaways
- Melanotan II has no approved product and no lawful compounding pathway, so any supply is unregulated.
- Tested online products did not reliably contain what their labels claimed.
- Case reports document rhabdomyolysis, renal infarction, priapism, new and darkening moles, and oral pigment changes.
- The mole effect actively interferes with catching skin cancer early.
- DHA sunless tanners give color without systemic risk, and afamelanotide is a supervised product for a rare disease, not cosmetics.
Frequently asked questions
Is melanotan II an approved tanning drug?
No. There is no FDA-approved melanotan II product and no lawful compounding pathway for it. Products sold online as tanning peptides are unapproved and unregulated, and their contents have been shown to vary from what the label claims.
How is afamelanotide different from melanotan II?
Afamelanotide is a related but distinct molecule that went through clinical trials and regulatory review for a rare light-sensitivity disorder called erythropoietic protoporphyria. It is a supervised medical product for a narrow indication, not a cosmetic tanning agent.
What harms have been documented with melanotan II?
Published case reports describe rhabdomyolysis and systemic toxicity, renal infarction, prolonged and painful priapism, new and darkening moles, and changes in the lining of the mouth. These are individual reports, not rates, but they are consistent and clinically serious.
Does it change existing moles?
There are reports of pre-existing moles darkening and new pigmented lesions appearing after even a single injection. Because changing moles are also how melanoma is spotted, that effect works directly against skin cancer surveillance.
Is there a safe way to get the same tan?
No injectable shortcut has been shown safe for cosmetic tanning. Topical sunless tanners using DHA color the outer skin layer without stimulating pigment production, and they carry none of the systemic risks documented for melanotan II.
